http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007094779-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a894c3abec424192fa9a8329256e7392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c24e09e8b5f794ffca99d42cd8f10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc245163bbdaa6eb660183d40fac2d45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e3f538daefb645d98fec27f1b5a0e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c6819fa5a8d335b99713940789a7664
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865033798fe64548598c3bb07aa7dbdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281f57549e5e3e8d3638db92e641462b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d528fe49f7e729128d4b3d8657b92b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db65cf0a4c27e22a2a8f34cb92641528
publicationDate 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007094779-A1
titleOfInvention Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
abstract The present invention provides pharmaceutical compositions comprising aliphatic amine polymers such as for example Sevelamer HCl as the active pharmaceutical ingredient, wherein the aliphatica amine polymers are spray granulated. The present invention further provides methods of preparing stable pharmaceutical compositions of aliphatic amine polymers such as for example Sevelamer HCl, preferably in tablets dosage forms.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008062437-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008062437-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011047700-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102993348-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013093939-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2545907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-024699-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010149794-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010149230-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9849147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010086881-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2441779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010041268-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009034540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102993348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013093939-A2
priorityDate 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002035089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0997148-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1153940-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135736840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128597033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10415276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127557586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829

Total number of triples: 89.